Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

NCT06225011 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Adenocarcinoma

Interventions

DRUG: Fluoxetine

Sponsor

Jonsson Comprehensive Cancer Center